Confirmatory Study of OPC-12759 Ophthalmic Suspension

PHASE3CompletedINTERVENTIONAL
Enrollment

188

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

March 31, 2010

Study Completion Date

April 30, 2010

Conditions
Dry Eye Syndromes
Interventions
DRUG

OPC-12759 Ophthalmic suspension

OPC-12759 Ophthalmic suspension 2%

DRUG

Hyalein Mini Ophthalmic solution

Hyalein Mini Ophthalmic solution 0.1%

Trial Locations (5)

Unknown

Kyushu region, Kagoshima

Chushikoku region, Matsuyama

Tokai region, Nagoya

Kansai region, Osaka

Kanto region, Tokyo

All Listed Sponsors
lead

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY